Related Experiment Videos

Early diagnosis of severe myoclonic epilepsy in infancy

M Yakoub1, O Dulac, I Jambaqué

  • 1Service de Neuropédiatrie, Hôpital Saint Vincent de Paul, Paris, France.

Brain & Development
|September 1, 1992
PubMed

Insights

Early diagnosis of severe myoclonic epilepsy in infancy (SMEI) is possible. Clinical patterns by the first year of life reliably identify SMEI, even before EEG abnormalities appear.

Area of Science:

  • Pediatric Neurology
  • Epilepsy Syndromes

Background:

  • Severe myoclonic epilepsy in infancy (SMEI) is a severe form of epilepsy.
  • Early diagnosis is crucial for effective management and improved outcomes.

Purpose of the Study:

  • To determine the reliability of diagnosing SMEI based on clinical presentation within the first year of life.

Main Methods:

  • Retrospective review of 329 epileptic patients with first seizure in the first year of life.
  • Inclusion criteria: generalized seizures (excluding specific types), afebrile seizures, normal prior development, normal CT, and unknown etiology.
  • Analysis of seizure patterns, EEG, and developmental status.

Main Results:

  • 17 out of 20 eligible patients (85%) developed SMEI.
  • SMEI pattern recognizable from the second or third seizure within the first year.
  • Epileptiform EEG abnormalities appeared later, between 11 and over 30 months.

Conclusions:

  • Clinical diagnosis of SMEI is highly reliable by the end of the first year of life.
  • Diagnosis can be made prior to definitive EEG findings.
  • Early clinical recognition facilitates timely intervention for SMEI.

Related Concept Videos